BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 1709854)

  • 1. Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
    Fitton A; McTavish D
    Drugs; 1991 Feb; 41(2):289-318. PubMed ID: 1709854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone.
    Coukell AJ; Markham A
    Drugs Aging; 1998 Feb; 12(2):149-68. PubMed ID: 9509293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
    Plosker GL; Goa KL
    Drugs; 1994 Jun; 47(6):945-82. PubMed ID: 7521833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pamidronate.
    Kellihan MJ; Mangino PD
    Ann Pharmacother; 1992 Oct; 26(10):1262-9. PubMed ID: 1421653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etidronic acid. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
    Dunn CJ; Fitton A; Sorkin EM
    Drugs Aging; 1994 Dec; 5(6):446-74. PubMed ID: 7858370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates: preclinical aspects and use in osteoporosis.
    Fleisch HA
    Ann Med; 1997 Feb; 29(1):55-62. PubMed ID: 9073324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibandronate.
    Dooley M; Balfour JA
    Drugs; 1999 Jan; 57(1):101-8; discussion 109-10. PubMed ID: 9951955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.
    Purohit OP; Radstone CR; Anthony C; Kanis JA; Coleman RE
    Br J Cancer; 1995 Nov; 72(5):1289-93. PubMed ID: 7577484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
    Wimalawansa SJ; Gunasekera RD
    Calcif Tissue Int; 1993 Oct; 53(4):237-41. PubMed ID: 8275351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bisphosphonate therapy of Paget's disease of bone with pamidronate].
    Grauer A; Klar B; Knaus J; Scharla SH; Ziegler R
    Med Klin (Munich); 1996 Jan; 91(1):14-9. PubMed ID: 8839196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates in the treatment of disorders of mineral metabolism.
    Singer FR; Minoofar PN
    Adv Endocrinol Metab; 1995; 6():259-88. PubMed ID: 7671099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical management of Paget's disease of bone: indications for treatment and review of current therapies.
    Siris ES; Lyles KW; Singer FR; Meunier PJ
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P94-8. PubMed ID: 17229018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease.
    Fleisch H
    Drugs; 1991 Dec; 42(6):919-44. PubMed ID: 1724640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: observations on regulation of serum calcium.
    van Breukelen FJ; Bijvoet OL; Frijlink WB; Sleeboom HP; Mulder H; van Oosterom AT
    Calcif Tissue Int; 1982 Jul; 34(4):321-7. PubMed ID: 6814719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biphosphonate therapy in the management of skeletal metastases].
    Grauer A; Ziegler R
    Orthopade; 1998 Apr; 27(4):231-9. PubMed ID: 9616882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates: an overview with special reference to alendronate.
    Vasikaran SD
    Ann Clin Biochem; 2001 Nov; 38(Pt 6):608-23. PubMed ID: 11732644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diphosphonates in the treatment of hypercalcemia].
    Delmas PD; Meunier PJ
    Rev Med Interne; 1984 Nov; 5(4):363-6. PubMed ID: 6240753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro.
    Reitsma PH; Teitelbaum SL; Bijvoet OL; Kahn AJ
    J Clin Invest; 1982 Nov; 70(5):927-33. PubMed ID: 7130396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of the role of bisphosphonates in metastatic disease.
    Ross JR; Saunders Y; Edmonds PM; Patel S; Wonderling D; Normand C; Broadley K
    Health Technol Assess; 2004; 8(4):1-176. PubMed ID: 14960258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From bathtub ring to osteoporosis: a clinical review of the bisphosphonates.
    Licata AA
    Cleve Clin J Med; 1993; 60(4):284-90. PubMed ID: 8339454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.